visinin-like 1 Antibody (3A9) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-25167JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Porcine, Bovine
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG1 Clone # 3A9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length human visinin-like 1 [UniProt# P62760]
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for visinin-like 1 Antibody (3A9) [Janelia Fluor® 635]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VSNL1
Long Name
Visinin Like 1
Alternate Names
HPCAL3, HUVISL1, VILIP, VISL1
Gene Symbol
VSNL1
Additional VSNL1 Products
Product Documents for visinin-like 1 Antibody (3A9) [Janelia Fluor® 635]
Product Specific Notices for visinin-like 1 Antibody (3A9) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...